Chairman of the Association of Pediatrics and member of the Immunization Committee, Prof. Tzachi Grossman, following the Pfizer study:

"Proving the effectiveness and safety of the vaccine at ages 5-11 is critical to protecting children and ending the epidemic. We will wait for FDA approval which should arrive within a few weeks, and after a discussion with the epidemic treatment team and the Supreme Vaccination Committee we will begin vaccination."